Home/Compugen/Henry Adewoye
HA

Henry Adewoye

Chief Financial Officer

Compugen

Therapeutic Areas

Compugen Pipeline

DrugIndicationPhase
COM701 (anti-PVRIG)Advanced solid tumorsPhase 1/2
COM902 (anti-TIGIT)Advanced solid tumorsPhase 1
Bispecific Antibody ProgramsUndisclosed cancersPreclinical